Skip to main content

Das28 Score Calculator

Calculate Disease Activity Score 28 for rheumatoid arthritis assessment. Enter values for instant results with step-by-step formulas.

Skip to calculator
Clinical Medicine

Das28 Score Calculator

Calculate the Disease Activity Score 28 (DAS28) for rheumatoid arthritis assessment. Supports both ESR and CRP versions with disease activity classification and EULAR response criteria.

Last updated: January 2026Reviewed by NovaCalculator Medical Editorial Team

Calculator

Adjust values & calculate
Clinical Tool: Enter joint counts (out of 28), acute phase reactant, and patient global assessment to calculate DAS28.
4
3
28
50
DAS28-ESR
4.64
Moderate Disease Activity
Disease Activity Scale
RemissionLowModerateHigh
02.63.25.18+
Activity Level
Moderate Disease Activity
DAS28 Score
4.64
Treatment Recommendation

Moderate disease activity. Consider treatment escalation. Options include optimizing current DMARD dose, adding a second conventional DMARD, or switching to a biologic or targeted synthetic DMARD. Re-assess in 3 months.

Disclaimer: This calculator is for clinical decision support. DAS28 should be interpreted in the context of the full clinical picture. Treatment decisions should be made in conjunction with rheumatology guidelines and patient preferences.
Your Result
DAS28-ESR: 4.64 | Moderate Disease Activity
Share Your Result
Understand the Math

Formula

DAS28-ESR = 0.56*sqrt(TJC) + 0.28*sqrt(SJC) + 0.70*ln(ESR) + 0.014*GH

TJC = tender joint count (0-28), SJC = swollen joint count (0-28), ESR = erythrocyte sedimentation rate (mm/hr), GH = patient global health assessment (0-100 VAS). For DAS28-CRP: 0.56*sqrt(TJC) + 0.28*sqrt(SJC) + 0.36*ln(CRP+1) + 0.014*GH + 0.96. Remission < 2.6, Low < 3.2, Moderate 3.2-5.1, High > 5.1.

Last reviewed: January 2026

Worked Examples

Example 1: Moderate RA Activity on Current DMARDs

A patient on methotrexate has 6 tender joints, 4 swollen joints, ESR of 35 mm/hr, and rates their global assessment at 55/100.
Solution:
Using DAS28-ESR formula: DAS28 = 0.56 x sqrt(6) + 0.28 x sqrt(4) + 0.70 x ln(35) + 0.014 x 55 DAS28 = 0.56 x 2.449 + 0.28 x 2.0 + 0.70 x 3.555 + 0.77 DAS28 = 1.371 + 0.560 + 2.489 + 0.770 DAS28 = 5.19
Result: DAS28-ESR: 5.19 | High Disease Activity | Consider adding biologic DMARD or switching therapy

Example 2: Patient Approaching Remission

After switching to a TNF inhibitor, a patient has 1 tender joint, 0 swollen joints, ESR of 8 mm/hr, and patient global of 15/100.
Solution:
Using DAS28-ESR formula: DAS28 = 0.56 x sqrt(1) + 0.28 x sqrt(0) + 0.70 x ln(8) + 0.014 x 15 DAS28 = 0.56 x 1.0 + 0.28 x 0 + 0.70 x 2.079 + 0.21 DAS28 = 0.560 + 0 + 1.455 + 0.210 DAS28 = 2.23
Result: DAS28-ESR: 2.23 | Remission (< 2.6) | Continue current treatment, monitor every 3-6 months
Expert Insights

Background & Theory

The Das28 Score Calculator applies the following established principles and formulas. Health and medicine calculators are grounded in validated physiological measurement methods established through decades of clinical research. Body Mass Index, or BMI, is calculated by dividing weight in kilograms by height in meters squared (kg/mยฒ), a formula originating from Adolphe Quetelet's 19th-century statistical work and later codified by the WHO into standard classifications: underweight below 18.5, normal weight 18.5 to 24.9, overweight 25 to 29.9, and obese at 30 and above. Basal Metabolic Rate quantifies the minimum energy required to sustain life at rest. The Mifflin-St Jeor equation, published in 1990 and widely regarded as the most accurate for most adults, calculates BMR as (10 ร— weight in kg) + (6.25 ร— height in cm) โˆ’ (5 ร— age) ยฑ sex adjustment. The older Harris-Benedict equations, revised in 1984 by Roza and Shizgal, remain in common use. Total Daily Energy Expenditure is derived by multiplying BMR by a physical activity factor ranging from 1.2 for sedentary individuals to 1.9 for extremely active ones, following the methodology validated by doubly labeled water studies. Body fat percentage can be estimated without laboratory equipment using the U.S. Navy circumference method, which uses neck, waist, and hip measurements, or via BMI-derived equations adjusted for age and sex. The Jackson-Pollock skinfold method offers higher precision with calipers. Blood pressure classification, according to the American College of Cardiology and the 2017 ACC/AHA guidelines, defines normal as below 120/80 mmHg, elevated as 120 to 129 systolic, and hypertension stage 1 as 130 to 139 systolic or 80 to 89 diastolic. Target heart rate zones for aerobic exercise are derived from maximum heart rate estimates, most commonly using the formula 220 minus age in years, with moderate-intensity training typically defined as 50 to 70 percent of maximum heart rate and vigorous intensity at 70 to 85 percent, consistent with CDC and American Heart Association guidelines. These thresholds guide safe and effective cardiovascular conditioning.

History

The history behind the Das28 Score Calculator traces back through the following developments. The history of health measurement stretches back to ancient Greece, where Hippocrates around 400 BCE laid the foundation for observational medicine by systematically recording patient symptoms, diet, and environment. His humoral theory, though scientifically superseded, established the principle that the body operates as an interconnected system subject to measurable imbalance. The transformation toward modern medicine accelerated in the 19th century. Louis Pasteur and Robert Koch developed germ theory in the 1860s and 1870s, identifying microorganisms as disease agents and enabling targeted interventions. Florence Nightingale, working during the Crimean War in the 1850s, introduced statistical analysis to nursing practice, demonstrating through data visualization that sanitation reduced mortality. Her work is foundational to evidence-based health measurement. The discovery of vitamins in the early 20th century, beginning with Casimir Funk's coinage of the term in 1912 and culminating in the isolation of vitamins A through K, created the field of nutritional science and gave rise to dietary reference intake frameworks. The World Health Organization, founded in 1948, subsequently established global standards for health metrics, disease classification through the International Classification of Diseases, and recommended daily allowances. The BMI as a clinical screening tool gained traction in the 1970s through Ancel Keys' large-scale epidemiological work, which validated Quetelet's index as a population-level obesity indicator. Through the 1980s and 1990s, the Framingham Heart Study produced landmark data linking cholesterol, blood pressure, and lifestyle factors to cardiovascular disease risk, directly shaping the numeric thresholds still used in health calculators. The evidence-based medicine movement, formalized by Gordon Guyatt and colleagues at McMaster University in the early 1990s, demanded that all health recommendations derive from systematically graded clinical evidence. The digital health era beginning in the 2000s brought these formulas to consumer devices, wearable sensors, and smartphone applications, expanding access to health self-monitoring on a global scale and enabling population-level data collection that continues to refine clinical reference ranges.

Share this calculator

Explore More

Frequently Asked Questions

The Disease Activity Score 28 (DAS28) is a validated composite measure used to quantify disease activity in rheumatoid arthritis (RA). It was developed by the European League Against Rheumatism (EULAR) and combines four variables: tender joint count (out of 28 joints), swollen joint count (out of 28 joints), an acute phase reactant (ESR or CRP), and a patient global assessment of disease activity on a visual analog scale. The DAS28 produces a single numerical value that categorizes disease activity into remission, low, moderate, or high. It is widely used in clinical practice for treatment decisions, in clinical trials as a primary outcome measure, and in treat-to-target strategies.
The DAS28 evaluates 28 specific joints bilaterally for tenderness and swelling. These include the proximal interphalangeal joints (10 joints, 5 per hand), metacarpophalangeal joints (10 joints, 5 per hand), wrists (2 joints), elbows (2 joints), shoulders (2 joints), and knees (2 joints). Notably, the DAS28 does not include the feet, ankles, hips, or temporomandibular joints, which is a recognized limitation since these joints are commonly affected in rheumatoid arthritis. The hips are excluded because they are difficult to assess clinically for swelling. The feet and ankles are omitted for practical reasons related to the original validation studies, though some clinicians supplement the DAS28 with foot examination.
DAS28-ESR and DAS28-CRP use different acute phase reactants and have slightly different formulas. DAS28-ESR uses erythrocyte sedimentation rate and the formula is 0.56 times the square root of tender joint count plus 0.28 times the square root of swollen joint count plus 0.70 times the natural log of ESR plus 0.014 times the patient global assessment. DAS28-CRP replaces ESR with C-reactive protein and uses adjusted coefficients. The two versions are not interchangeable as DAS28-CRP tends to give slightly lower scores than DAS28-ESR. The same version should be used consistently for longitudinal monitoring of individual patients. DAS28-CRP may be preferred in patients where ESR is unreliable.
The DAS28 score uses well-established thresholds to categorize rheumatoid arthritis disease activity into four levels. Remission is defined as a DAS28 score below 2.6, indicating minimal or absent disease activity and the ultimate treatment goal. Low disease activity is a score between 2.6 and 3.2, representing an acceptable therapeutic target when remission is not achievable. Moderate disease activity encompasses scores from 3.2 to 5.1, indicating the need for treatment adjustment. High disease activity is defined as a score above 5.1, signaling that aggressive treatment escalation is warranted. These thresholds were validated in the original DAS28-ESR studies and are widely accepted in clinical guidelines.
The EULAR response criteria use both the current DAS28 score and the change in DAS28 from baseline to classify treatment response. A good response requires both a DAS28 improvement greater than 1.2 AND a current DAS28 of 3.2 or less. A moderate response is defined as either a DAS28 improvement of 0.6 to 1.2 with a current DAS28 of 5.1 or less, OR an improvement greater than 1.2 with a current DAS28 above 3.2. No response means a DAS28 improvement of less than 0.6, OR an improvement of 0.6 to 1.2 with a current DAS28 above 5.1. These criteria provide a standardized framework for evaluating treatment effectiveness in both clinical practice and research trials.
The frequency of DAS28 measurement depends on the current disease activity level and treatment phase. During active disease or after a treatment change, DAS28 should be assessed every 1 to 3 months to evaluate treatment response and guide adjustments according to treat-to-target principles. Once a patient achieves remission or low disease activity on a stable treatment regimen, monitoring intervals can be extended to every 3 to 6 months. The ACR and EULAR guidelines recommend a treat-to-target approach where therapy is adjusted every 3 months until the target of remission or low disease activity is achieved. Consistent measurement intervals help track trends and enable meaningful comparison of scores over time.
Educational Note: This calculator is provided for educational and informational purposes. Results are based on the formulas and inputs provided. Always verify important calculations independently. NovaCalculator processes calculator inputs client-side; optional analytics follow visitor consent settings.Reviewed by: NovaCalculator Medical Editorial Team โ€” Reviewed against WHO, NIH, and peer-reviewed clinical sources. Last reviewed: January 2026. ยฉ 2024โ€“2026 NovaCalculator.

Share this calculator

Formula

DAS28-ESR = 0.56*sqrt(TJC) + 0.28*sqrt(SJC) + 0.70*ln(ESR) + 0.014*GH

TJC = tender joint count (0-28), SJC = swollen joint count (0-28), ESR = erythrocyte sedimentation rate (mm/hr), GH = patient global health assessment (0-100 VAS). For DAS28-CRP: 0.56*sqrt(TJC) + 0.28*sqrt(SJC) + 0.36*ln(CRP+1) + 0.014*GH + 0.96. Remission < 2.6, Low < 3.2, Moderate 3.2-5.1, High > 5.1.

Worked Examples

Example 1: Moderate RA Activity on Current DMARDs

Problem: A patient on methotrexate has 6 tender joints, 4 swollen joints, ESR of 35 mm/hr, and rates their global assessment at 55/100.

Solution: Using DAS28-ESR formula:\nDAS28 = 0.56 x sqrt(6) + 0.28 x sqrt(4) + 0.70 x ln(35) + 0.014 x 55\nDAS28 = 0.56 x 2.449 + 0.28 x 2.0 + 0.70 x 3.555 + 0.77\nDAS28 = 1.371 + 0.560 + 2.489 + 0.770\nDAS28 = 5.19

Result: DAS28-ESR: 5.19 | High Disease Activity | Consider adding biologic DMARD or switching therapy

Example 2: Patient Approaching Remission

Problem: After switching to a TNF inhibitor, a patient has 1 tender joint, 0 swollen joints, ESR of 8 mm/hr, and patient global of 15/100.

Solution: Using DAS28-ESR formula:\nDAS28 = 0.56 x sqrt(1) + 0.28 x sqrt(0) + 0.70 x ln(8) + 0.014 x 15\nDAS28 = 0.56 x 1.0 + 0.28 x 0 + 0.70 x 2.079 + 0.21\nDAS28 = 0.560 + 0 + 1.455 + 0.210\nDAS28 = 2.23

Result: DAS28-ESR: 2.23 | Remission (< 2.6) | Continue current treatment, monitor every 3-6 months

Frequently Asked Questions

What is the DAS28 score and why is it used?

The Disease Activity Score 28 (DAS28) is a validated composite measure used to quantify disease activity in rheumatoid arthritis (RA). It was developed by the European League Against Rheumatism (EULAR) and combines four variables: tender joint count (out of 28 joints), swollen joint count (out of 28 joints), an acute phase reactant (ESR or CRP), and a patient global assessment of disease activity on a visual analog scale. The DAS28 produces a single numerical value that categorizes disease activity into remission, low, moderate, or high. It is widely used in clinical practice for treatment decisions, in clinical trials as a primary outcome measure, and in treat-to-target strategies.

Which 28 joints are assessed in the DAS28?

The DAS28 evaluates 28 specific joints bilaterally for tenderness and swelling. These include the proximal interphalangeal joints (10 joints, 5 per hand), metacarpophalangeal joints (10 joints, 5 per hand), wrists (2 joints), elbows (2 joints), shoulders (2 joints), and knees (2 joints). Notably, the DAS28 does not include the feet, ankles, hips, or temporomandibular joints, which is a recognized limitation since these joints are commonly affected in rheumatoid arthritis. The hips are excluded because they are difficult to assess clinically for swelling. The feet and ankles are omitted for practical reasons related to the original validation studies, though some clinicians supplement the DAS28 with foot examination.

What is the difference between DAS28-ESR and DAS28-CRP?

DAS28-ESR and DAS28-CRP use different acute phase reactants and have slightly different formulas. DAS28-ESR uses erythrocyte sedimentation rate and the formula is 0.56 times the square root of tender joint count plus 0.28 times the square root of swollen joint count plus 0.70 times the natural log of ESR plus 0.014 times the patient global assessment. DAS28-CRP replaces ESR with C-reactive protein and uses adjusted coefficients. The two versions are not interchangeable as DAS28-CRP tends to give slightly lower scores than DAS28-ESR. The same version should be used consistently for longitudinal monitoring of individual patients. DAS28-CRP may be preferred in patients where ESR is unreliable.

What DAS28 thresholds define disease activity levels?

The DAS28 score uses well-established thresholds to categorize rheumatoid arthritis disease activity into four levels. Remission is defined as a DAS28 score below 2.6, indicating minimal or absent disease activity and the ultimate treatment goal. Low disease activity is a score between 2.6 and 3.2, representing an acceptable therapeutic target when remission is not achievable. Moderate disease activity encompasses scores from 3.2 to 5.1, indicating the need for treatment adjustment. High disease activity is defined as a score above 5.1, signaling that aggressive treatment escalation is warranted. These thresholds were validated in the original DAS28-ESR studies and are widely accepted in clinical guidelines.

What is the EULAR response criteria using DAS28?

The EULAR response criteria use both the current DAS28 score and the change in DAS28 from baseline to classify treatment response. A good response requires both a DAS28 improvement greater than 1.2 AND a current DAS28 of 3.2 or less. A moderate response is defined as either a DAS28 improvement of 0.6 to 1.2 with a current DAS28 of 5.1 or less, OR an improvement greater than 1.2 with a current DAS28 above 3.2. No response means a DAS28 improvement of less than 0.6, OR an improvement of 0.6 to 1.2 with a current DAS28 above 5.1. These criteria provide a standardized framework for evaluating treatment effectiveness in both clinical practice and research trials.

How often should DAS28 be measured in clinical practice?

The frequency of DAS28 measurement depends on the current disease activity level and treatment phase. During active disease or after a treatment change, DAS28 should be assessed every 1 to 3 months to evaluate treatment response and guide adjustments according to treat-to-target principles. Once a patient achieves remission or low disease activity on a stable treatment regimen, monitoring intervals can be extended to every 3 to 6 months. The ACR and EULAR guidelines recommend a treat-to-target approach where therapy is adjusted every 3 months until the target of remission or low disease activity is achieved. Consistent measurement intervals help track trends and enable meaningful comparison of scores over time.

References

Reviewed by Rahul Singh, Health & Wellness Specialist ยท Editorial policy